Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Perfect!!!! LMAO! eom
BRCD - earnings news... Brocade Reports Second Quarter Fiscal Year 2006 Results
May 18, 2006 16:15:34 (ET)
SAN JOSE, Calif., May 18, 2006 /PRNewswire-FirstCall via COMTEX/ -- Brocade Communications Systems, Inc. (Brocade(R)) (BRCD, Trade) today reported financial results for its second quarter of fiscal year 2006 (Q2 06), which ended April 29, 2006. Net revenues for Q2 06 were a record $182.7 million. Revenues for the quarter increased 7 percent from $170.1 million reported in the first quarter of fiscal year 2006 (Q1 06) and increased 26 percent from $144.8 million reported in the second quarter of fiscal year 2005 (Q2 05).
Reporting on a GAAP basis, net income for Q2 06 was $13.5 million, or $0.05 per share basic and diluted. This compares to GAAP net income for Q1 06 of $9.7 million, or $0.04 per share basic and diluted, and GAAP net income for Q2 05 of $21.4 million, or $0.08 per share basic and diluted.
Non-GAAP net income for Q2 06 was $26.4 million, or $0.10 per share basic and diluted, as compared to non-GAAP net income for Q1 06 of $25.9 million, or $0.10 per share basic and diluted, and non-GAAP net income for Q2 05 of $19.1 million, or $0.07 per share basic and diluted. Non-GAAP net income for Q2 06 excludes net stock-based compensation expenses, amortization of stock compensation expense related to acquisitions, amortization of intangible assets, costs associated with facilities lease losses, compensation expense related to acquisitions, costs associated with the Company's ongoing SEC investigation, and associated tax effects of non-GAAP adjustments. Non-GAAP net income for Q1 06 excludes net stock-based compensation expenses, amortization of stock compensation expense related to acquisitions, costs associated with the completed internal review and ongoing SEC investigation, provision for an estimated settlement with the SEC, and associated tax effects of non-GAAP adjustments. Non-GAAP net income for Q2 05 excludes net stock-based compensation benefits, gains related to repurchases of convertible subordinated debt, gains on dispositions of marketable investments, amortization of stock compensation expense related to acquisitions, a reduction of previously recorded restructuring costs, costs associated with internal review and the ongoing SEC investigation, severance expense included in general and administrative, and associated tax effects of non-GAAP adjustments. A reconciliation between GAAP and non-GAAP information is contained in the tables below.
"Our results for the second quarter of fiscal 2006 were outstanding and exceeded our expectations for what is historically a seasonally soft quarter," said Michael Klayko, Brocade Chief Executive Officer. "We saw balanced strength across all aspects of our core SAN business and continued progress in our newer Services and Tapestry initiatives."
Here's what the Freaking FED said...
snip....
"William Poole, president of the St. Louis Federal Reserve Bank said he didn't know if the Federal Reserve would raise its short-term federal funds rate "50 basis points" -- a half percentage point -- or cut the rate a half percentage point. In fact, Poole didn't say what the Fed will do. That depends on economic data. But what unglued stock investors, apparently, was that he used the phrase 50 basis points."
What a friggin answer. Should appoint him head of the FDA or IRS or Homeland security.
Dumbass. imho.
Maria Bartiromo? eom
UVCL running....news - UniverCell Holdings, Inc. and Daytonabrands Sign Definitive Merger Agreement
PrimeZone Media Network - May 18, 2006 2:21 PM (EDT)
Jump to first matched term
By Staff
MIAMI BEACH, Fla., May 18, 2006 (PRIMEZONE via COMTEX) -- UniverCell Holdings, Inc. (OTCBB:UVCL) and Daytonabrands, Inc announced today that they have entered into a definitive Agreement and Plan of Merger.
Daytonabrands is a consumer and OEM products company focusing on the $29 billion automotive aftermarket and accessories industry. The company's key management has significant consumer products experience coming from such respected companies as ArmorAll, Disney (DIS), ProTeam, ConAgra (CAG), Clorox (CLX) and further including Alan Rypinski, International Marketing Guru and Founder of ArmorAll Corporation.
Daytonabrands distributes products directly to consumers via infomercial television (DRTV), print media and national catalog publications such as SkyMall. Retailers include Albertson's/Sav-On Drug Stores (ABS), Costco (COST), Ace Hardware, CSK (CAO), Schucks, Checker, Kragen, Advance Auto (AAP), AutoZone (AZO), Walgreens (WAG) and others. The company also sells as OEM for branded names such as Craftsman (SHLD), Genie and Shell.
Scott Harkness, President of Daytonabrands, stated, "Our powerhouse team consists of ArmorAll Corporation founder, former President and CEO, Alan Rypinski and others from ProTeam, ConAgra, Disney and Clorox. Our products are widely accepted by consumers. Our newly constructed 150 member sales team is primarily comprised of former ArmorAll sales and distribution representatives. All combined, Daytonabrands, Inc. is poised to expand product offerings and be a significant player in the $29 Billion automotive aftermarket accessories industry."
The Agreement and Plan of Merger provides for the merger of a wholly owned subsidiary of UniverCell into Daytonabrands. As a result of the merger, the shareholders of Daytonabrands will receive shares of UniverCell common stock for their Daytonabrands shares.
The proposed merger is subject to certain customary conditions, including UniverCell and Daytonabrands receiving shareholder and regulatory approval.
"This has been a long time in the making and we are confident that the Daytonabrands team will bring a tremendous increase in shareholder value. After searching for a merger candidate which would increase shareholder value for the UniverCell shareholders, we are very pleased to sign this definitive agreement and we plan to effectuate the merger by the end of the month," Sean Y. Fulda, UniverCell's Chief Executive Officer, stated.
"We look forward to completing our merger with UniverCell," said Scott Harkness, President of Daytonabrands. "We are excited at being part of a public company, which we believe will allow us to further our growth strategy to make Daytonabrands an industry leader in the $29 Billion automotive aftermarket accessories industry."
Statements about the Company's future expectations, including future revenues and earnings, and all other statements in this press release other than historical facts are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements shall be subject to the safe harbors created thereby. Since these statements involve risks and uncertainties and are subject to change at any time, the Company's actual results could differ materially from expected results.
This news release was distributed by PrimeZone, www.primezone.com
SOURCE: UniverCell Holdings, Inc.
UniverCell Holdings, Inc.
Sean Y. Fulda
(786) 276-7817
sean@rentalcell.com
more zixi news.... Zix Corporation Selected by McQueary Henry Bowles Troy for Email Encryption Services; North Texas` Largest Independent Insurance Firm Opts for Three-Year ZixVPM(R), ZixPort(R) Contract
May 18, 2006 13:43:01 (ET)
DALLAS, May 18, 2006 (BUSINESS WIRE) -- Zix Corporation (ZixCorp(R)) (ZIXI, Trade) the leader in hosted services for email encryption and e-prescribing, today announced that McQueary Henry Bowles Troy, L.L.P. (MHBT), one of the largest privately owned insurance and risk management firms in the United States has signed a three-year contract for ZixVPM (Virtual Private Messenger) and ZixPort email encryption services.
ZixVPM will enforce MHBT's email security policies to ensure secure handling of sensitive data for 300 users. The service includes pre-configured lexicons that automatically detect and encrypt emails containing financial data and protected health information (PHI) to help comply with privacy rules of GLBA and HIPAA. ZixPort provides custom branding and encrypted messaging functionality to the organization's Web site.
"Many of our customers and carriers are already ZixCorp users, which made it an easy choice," said Mike Harris, director of information technology for MHBT. "We take protection of private data seriously and plan to install a second ZixVPM device to ensure encryption will occur even if our primary Internet connection goes down."
Based in Dallas, MHBT has been ranked among the Top 100 Brokers in the United States by Business Insurance from 2000-2005, one of the 50 Best Companies to Work For in Texas by Texas Monthly in 2006, and recognized as one of the Best Places to Work in Dallas-Fort Worth by Dallas Business Journal from 2003-2006.
"Last month, smaller health plans had to meet a HIPAA security deadline to ensure that covered entities protect PHI in their email, and this event has helped fuel our increase in email encryption customers," said Rick Spurr, chief executive officer for ZixCorp. "Having firms such as MHBT join the network of email encryption users makes communications and interoperability in the healthcare community easy and secure."
About MHBT
MHBT is based in Dallas and also has offices in Fort Worth and Austin, Texas. MHBT and its precursors have offered global insurance, bonds, and financial services since 1927. The firm offers commercial risk management and insurance services, employee benefits, and financial services, construction bond services, property and casualty insurance, personal insurance, and surety and specialized services. For the past five years, Business Insurance has ranked MHBT as one of the top 100 commercial insurance firms in the United States. For more information, visit the firm's Web site at www.mhbt.com.
LMAO!! photoshop huh! Game OVER! Z
Burgers!!! droooool :-p hamburgersssss....hmmmmmm! eom
join the 21st century dude!
JK!
lol!
Z
crazy fuck. imho. eom
beat it gorillanoc! Till them stfu!
jk
Z
ZephyrWoods strikes again! 15 holes in 1
could have been better....we'll see. eom
MKTY - moving on their news this morning ))))) MTI MicroFuel Cells Announces Strategic Alliance With Samsung Electronics
May 18, 2006 05:55:14 (ET)
ALBANY, N.Y., May 18, 2006 /PRNewswire-FirstCall via COMTEX/ -- MTI MicroFuel Cells Inc. (MTI Micro), developer of the award-winning Mobion(R) micro fuel cell technology for handheld electronic devices and a subsidiary of Mechanical Technology Incorporated (MTI) (MKTY, Trade), today announced an exclusive alliance with Samsung Electronics Co., Ltd., ("Samsung"), a technology innovator in the telecommunications industry, to develop next-generation fuel cell prototypes for Samsung's mobile phone business. Mobion(R), MTI Micro's patented direct methanol fuel cell (DMFC) technology, has been chosen to power a series of prototypes designed for Samsung's mobile phone and mobile phone accessories.
Frost & Sullivan, an industry research firm, estimates that Samsung is the third largest handset manufacturer in terms of units shipped in the market for mobile handsets worldwide. Further, Frost & Sullivan forecasts the market for micro fuel cells for consumer electronic devices to reach approximately 80 million units by 2012.
"MTI Micro's alliance with Samsung is a significant step towards direct methanol fuel cell commercialization. As today's consumer electronic devices are becoming increasingly power hungry and multi-functional, conventional rechargeable batteries are challenged to provide the required runtime consumers demand. Micro fuel cells are expected to provide the solution to this challenge," said Sara Bradford, Research Director, Power Systems Group, for Frost & Sullivan.
Due to its anticipated longer runtime and instant recharging advantages (compared with batteries in today's mobile phones), Mobion(R) is being designed as the advanced power solution which will allow future consumers to enjoy media-rich, power hungry mobile applications. Samsung and MTI Micro are teaming together to leverage Mobion(R)'s intrinsic technological advantages to enable new features for future mobile phones that, until now, have been constrained by traditional battery power sources.
Together, the two companies will develop, test, and evaluate Mobion(R) technology for various mobile phone applications. Samsung will put its resources into this joint effort which will help determine the best approach for powering the next-generation of feature-rich devices in the consumer electronics industry. Upon successful completion of this agreement, MTI Micro and Samsung intend to continue to work together by entering into a product commercialization agreement.
"By allying with MTI Micro, Samsung is empowered to go beyond the established boundaries of what is currently possible with mobile phone design and functionality. Samsung continuously pushes forward to overcome one of the most challenging issues of the mobile industry and continue to lead the market with this leading edge technology," said YoungWoo Lee, Vice President at Samsung Electronics.
MTI Micro's strategy is to provide a DMFC power source to a wide range of portable consumer electronic devices, from digital cameras to mobile phones to handheld entertainment devices. MTI Micro has focused on developing key partnerships in all aspects of its business including materials, manufacturing, and distribution. Today's agreement with Samsung is preceded by an impressive list of alliances MTI Micro has established to create a world-class supply chain. With these relationships in place, MTI Micro is poised to advance Mobion(R) as the key power source in the consumer electronics marketplace.
"Samsung is one of the largest and most innovative mobile phone suppliers in the world and I am pleased that MTI Micro has this exclusive opportunity to team with them and explore advanced power solutions for their future mobile phone products," said Peng Lim, President and CEO of MTI Micro. "Our goal is to make Mobion(R) a standard power source used for powering all types of mobile products, and under this agreement, our work with Samsung on mobile phones and accessory applications will be a major step in achieving that goal."
23 14 holes in 1
24 14 in 1
Sure you believe him! as to those couple of holes.....I'm thinking about mmmm.....)))))))))
BOL - moving up on the news update...
Bausch & Lomb Clarifies Reporting of Fusarium Keratitis Cases to FDA
May 17, 2006 12:01:01 (ET)
ROCHESTER, N.Y., May 17, 2006 (BUSINESS WIRE) -- Bausch & Lomb wishes to clarify information contained in media reports about the U.S. Food and Drug Administration's inspection of Bausch & Lomb's manufacturing plant and distribution facility in Greenville, S.C., that erroneously suggest that Bausch & Lomb withheld from FDA information the Company received about Fusarium infections in Singapore.
The media reports followed FDA's release yesterday of its inspection's preliminary observations, one of which noted that the Company "... failed to notify the Agency of 35 serious injury reports of Fusarium keratitis from Singapore's Minister of Health in February 2006 relating to ReNu(R) MoistureLoc Multipurpose Solution."
Within days of receiving a report in February of an unusual spike of Fusarium keratitis cases among contact lens wearers in Singapore, Bausch & Lomb discussed those initial case reports with FDA's Office of Compliance in the Center for Devices and Radiological Health. As details of the Singapore cases were gathered, the Company continued to provide updates to FDA. On April 5, Company representatives met in person with agency representatives to provide a full briefing on its Fusarium investigation activities. After receiving guidance from FDA on its preferences for the content and form of the formal report, Bausch & Lomb filed the Medical Device Report on April 7.
FDA's preliminary observations also noted that unspecified "keratitis complaints" reported to the Company in July 2005 were not reported to the agency. Those six reports of noninfectious keratitis, or general eye inflammation, among contact lens wearers were not related to Fusarium infections and did not require medical treatment. Bausch & Lomb followed guidelines developed for use by all contact lens and lens-care product manufacturers that were adopted by the Contact Lens Institute in 1997 and provided to FDA. These guidelines were developed by the industry association to assist its members in complying with FDA medical device reporting requirements. Under these guidelines, noninfectious eye inflammations not requiring medical treatment to preclude permanent damage or impairment are not considered to be reportable. The Company will be working with the agency to assess whether these guidelines should continue to be referenced in future reporting decisions.
Bausch & Lomb continues to work closely with FDA to address all issues in its preliminary report of the Greenville plant inspection and remains committed to maintaining its operations in compliance with all regulatory requirements and good manufacturing practices.
ahhh. I'll try that. good idea. TX eom
Your on dude! Figured out how to make a pdf of the screen....then save it as a jpeg...post it on a free site...then load it here. fucking work around....only problem (for you!) is that the jeg shows up small...but readable...just barely. lol!
test
LOL guess not. Don't have that option on MAC....I'll have to have my mac tech guy give me the solution....Then I'm going to Kick Butt!
sorry dude...you need to beat mine....Posted by: Zephyr
In reply to: None
Date:5/10/2006 6:40:26 PM
Post #of 121627
23 14 in 1's eom
Try'd to capture a screen shot of the score....how you do that? Couldn't figure that out on my mac.
IRIS - continues rise.
Starter in NBIX @ $20.20. eom
From the Motley Fool on NBIX - The FDA Tries to Put Neurocrine to Sleep
By Stephen D. Simpson, CFA (TMFWildWeasel)
May 16, 2006
If you're a Neurocrine Biosciences (Nasdaq: NBIX) investor, this is a terrible day. If you're a DOV Pharmaceuticals (Nasdaq: DOVP) investor, you might feel stuck in a waking nightmare. If you're a Pfizer (NYSE: PFE) investor, you probably just shrug and move on to the next bit of news.
Before Tuesday's open, Neurocrine announced that the Food and Drug Administration had issued approvable letters for the 5 mg and 10 mg versions of Indiplon, the company's promising insomnia drug, but not for the 15 mg extended-release version. This is not a case where the best two out of three wins -- there's some modest market opportunity for the lower doses, but it was the 15 mg dose that was to be the centerpiece to the story.
That's bad news, of course, but it's not completely unheard of -- FDA rejections are an unfortunate part of the biotech/pharmaceutical process. What really fired me up, though, was the wording in the press release -- "the FDA indicated that they did not have an opportunity to review all of the information submitted during the NDA review cycles."
What? Were the FDA folks in a rush to get home to watch American Idol? Were they too busy playing World of Warcraft? Of all the reasons, rationale, and excuses I've heard for rejecting a drug application, "we didn't have time to look at your data" has to score as the worst -- presuming that I'm interpreting this statement correctly. Seriously, even though I don't own any of these shares, this is the sort of thing that angries up the blood and makes me wonder whether the whole FDA should be scrapped and rebuilt.
So, what now?
Well, I don't see Pfizer really wanting to bother launching Indiplon without an extended-release formula. So maybe the best-case scenario is that I'm reading this statement correctly and the FDA simply couldn't review all of the clinical data by the decision's due date -- thereby raising the possibility that it could be approved later. Although that's not good news, since it gives competitors time to dig in, it's better than nothing for Neurocrine and DOV, which originally licensed the drug to Neurocrine after in-licensing it from Wyeth (NYSE: WYE) a while ago.
Setbacks aren't always terminal -- as Elan (NYSE: ELN) and Biogen Idec (Nasdaq: BIIB) hope to soon experience -- though they are difficult. My gut instinct is to tell the investors in the biotechs to hang on, but I can't and won't pretend that this is going to be easy. I'm a longtime fan of Neurocrine, though, so my hope is that this all ends up working out for the company and its investors.
Brig - careful yes...but it's not a "failure"...It's more about the submission that they presented was not prepared correctly for the FDA....FDA admits they didn't review the entire submission. (That's the clue.) It'll take an appeal and a resubmission but it'll be approved. The drug itself didn't fail per their testing results.
It may not have bottomed...but it's probably close...and just like ELN it'll bounce in due time. IMHO.
Watching NBIX for a bounce play... eom
IRIS looks like it trying hard to continue the bounce today. ) eom
ZIXI news...Zix Corporation Selected by VHHA Services as Exclusive Email Encryption Vendor
May 16, 2006 11:51:01 (ET)
DALLAS, May 16, 2006 (BUSINESS WIRE) -- Zix Corporation (ZixCorp(R)), (ZIXI, Trade), the leader in hosted services for email encryption and e-prescribing, today announced it has been endorsed as the exclusive authorized email encryption vendor of VHHA Services, Inc., the shared services affiliate of the Virginia Hospital & Healthcare Association.
The relationship will enable VHHA members to purchase ZixCorp email encryption services through VHHA Services. The selection follows other hospital and payor cooperatives that have chosen ZixCorp as a preferred vendor, including VHA Georgia, the Georgia Hospital Association, The New Jersey Hospital Association, the Arizona Hospital and Healthcare Association, All Health, and the Blue Cross Blue Shield Association. The VHHA has 51 member health systems and hospitals, representing 99 community, psychiatric and specialty hospitals throughout Virginia.
"ZixCorp services will help us build a secure network of healthcare providers across Virginia that routinely protects all sensitive medical, personal and financial information," said Tom Northrop, vice president and chief operating officer for VHHA Services. "Secure messaging is a vital area for our hospitals. ZixCorp delivers quality, cost-efficiency, and outstanding performance in secure messaging across all portions of a hospital or health system, including doctor's offices. ZixCorp will protect our member health care organizations from the risk of having protected health information (PHI) being leaked via email, and ZixCorp can help stop those data leaks quickly and easily."
VHHA Services identifies, evaluates, and markets the services and products of a number of strategic business partners who deliver superior services to VHHA member hospitals. It seeks to inform members of available resources and to ensure that VHHA hospitals receive the highest performance possible from each business partner's resources.
"We're continuing to solidify new alliances and partnerships and the addition of VHHA is the type of quality relationship we're creating to build on our network of 4,200 customers with over four million protected email addresses," said Rick Spurr, chief executive officer for ZixCorp. "We're excited to be selected and look forward to increasing our presence in this strategic geography."
About VHHA
The Virginia Hospital & Healthcare Association is an alliance of hospitals and health delivery systems that develops and advocates health care policy for the Commonwealth. Its vision is to achieve excellence in both health care and health. For more information, visit www.vhha.com.
Yes ELN very strong...watchout if thalio shorts. eom
thalio - your short paid off? eom
BOL SWEEEEEET! ))))) eom
ELN sweet...looking for a lot more...3rd quarter.
I got the cajones to hold till 9 )))))eom
XNN - strong move up today after yesterday's earnings news...
Picked up more ELN.
thalio - scalping is good! LOL! eom
Painterguy - their solution is approx. 100 million of 2+ billion dollars in sales annually. While they will also be revising some revenue in past quarters/year(s) and put some $'s on the sideline to manage the legal ramifications...bottom is in IMHO.
pink eye LOL! eom